Literature DB >> 21432219

Clinical factors associated with severity in hospitalized children infected with avian influenza (H5N1).

Hiroyuki Furuya1, Shoji Kawachi, Mika Shigematsu, Kazuo Suzuki, Tetsu Watanabe.   

Abstract

OBJECTIVE: The World Health organization received reports of 478 laboratory-confirmed cases of influenza A (H5N1) from 15 countries between November 2003 and February 2010. More than 50% of these cases involved patients <20 years of age. Determining an association between the clinical factors at the time of hospital admission and prognosis may be useful for timely and adequate consultation and treatment. It has been difficult to obtain these clinical factors adjusted with other confounding factors, such as age and sex, as published studies of H5N1 virus infection usually reported only a few cases. So, we performed a pooled analysis of the reported cases.
METHODS: Five case reports (36 patients <18 years of age) of H5N1 infection from four countries published between 2004 and 2009 were assessed based on available individual clinical data. Using the pooled data for all patients, we investigated the associations between patients' prognosis and available laboratory findings, such as white blood cell (WBC) counts, platelet (PLT) counts, and serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) by adjusting for age and/or sex.
RESULTS: The linear regression analysis revealed that mortality was negatively associated with WBC and PLT counts adjusted with age and sex. Increased log AST tended to be associated with a poor prognosis (p = 0.054), but there was no significant association between survival and log ALT level.
CONCLUSIONS: Both decreased WBC and PLT counts can be considered to be common predictors of poor prognosis in H5N1 influenza patients <18 years of age. Further studies are needed for clarification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21432219      PMCID: PMC2999688          DOI: 10.1007/s12199-010-0158-x

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


Introduction

The 2009 H1N1 influenza pandemic spread throughout the world, but since the beginning of 2010, the number of cases of this influenza has been declining. Reports of avian influenza (H5N1) infection in humans have also been reported, raising the threat of a new pandemic through a novel combination of the H5N1 virus with the 2009 H1N1 strain. Cases of the highly pathogenic avian influenza A virus (H5N1) causing influenza symptoms in humans were observed in the Hong Kong Special Administrative Region, People’s Republic of China in 1997 [1]. A total of 478 laboratory-confirmed cases of influenza A (H5N1) infection were subsequently reported to the World Health Organization (WHO) from 15 countries between November 2003 and February 2010 [2]. More than 90% of these cases were reported in five countries, namely, Indonesia, Vietnam, Egypt, China, and Thailand. Patients <20 years of age accounted for 63% of the cluster cases and 49% of the sporadic cases [3]. The case-fatality rate (CFR) in all cases was 62.1. Of the 383 cases reported between November 2003 and May 2008 from these 15 countries, 10.4% involved patients aged <9 years, 24% involved patients between ages 10 and 19 years, and 25% involved patients aged 20–29 years [4]. The overall CFR of H5N1 infection was 65%, and the CFR for patients aged 10–19 years was 78%, which was highest among all age groups [4]. Patients for whom the disease was ultimately fatal showed respiratory failure and progressed to pediatric acute respiratory distress syndrome (ARDS), which in patients infected with H5N1 influenza virus consisted of severe viral pneumonia accompanied by diffuse alveolar damage that was induced by intense cytokine reactions and inflammation [5]. Wiwanitkit investigated hematologic findings among reported H5N1-infected patients and observed lymphopenia and anemia, but he did mentioned that the effects of the infection on platelet count were controversial [6]. A knowledge of the clinical factors present at admission to the hospital that are associated with prognosis may be useful when the aim is timely and adequate consultation and treatment. As many of the studies on the H5N1 virus have each only reported a few cases of H5N1 influenza, it has been difficult to get identify these clinical factors adjusted with other confounding factors, such as age and sex. Here, we report our investigation of the early indicators of prognosis in patients with H5N1 influenza aged <18 years which we identified from a pooled analysis of case reports.

Methods

For the case-investigation of H5N1 human infection reports containing individual clinical data, we selected five case reports from four countries published between 2004 and 2009 for investigation. From each report, we selected patients aged <18 years; ultimately, our study population consisted of 36 patients who were included in the pooled analysis. Four patients were from Tran et al. [7] (Vietnam), 12 were from Kawachi et al. [5] (Vietnam), 7 were from Chotpitayasunondh et al. [8] (Thailand), 8 were from Oner et al. [9] (Turkey), and 5 were from Kandun et al. [10] (Indonesia). H5N1 case-patients were identified by reverse transcriptase (RT)-PCR. The patients reported in Kawachi et al. [5] who showed severe ARDS were identified in the National Hospital of Pediatrics (NHP), and those in other reports were from passive surveillance. We investigated factors related with patients’ prognosis from available laboratory findings, such as white blood cell (WBC) counts, platelet (PLT) counts, and serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The AST and ALT levels were not available for the cases of Kandun et al. [10] and five cases from Kawachi et al. [5], and the leukocyte and platelet counts were not available for one case from Kawachi et al. [5]. Data were analyzed using Wilcoxon and Kruskal–Wallis tests for continuous variables and Fisher’s exact test for categorical variables. Linear regression analysis was used for investigating associations between laboratory findings and patients’ prognosis. All statistical analyses were done by SPSS ver. 14.0J (SPSS, Chicago, IL).

Results and discussion

We summarized the characteristics of patients from each report in Table 1. The mean age of the pooled patients from all studies was 8.0 ± 4.4 years, and mean ages of the patients were significantly different among the different reports (p = 0.032). For the pooled data, the proportion of patients who showed ARDS or respiratory failure during hospitalization was 75%; this proportion was also significantly different among the different reports (p = 0.014). Overall, the CFR was 69.4%, and no significant difference between reports was observed. For the pooled data, median number of days from onset to admission was 6.0 and the median number of days from onset to outcome was 14.0; there no significant differences among the reports for both data sets.
Table 1

Characteristics of patients from each report

NR not reported, ARDS acute respiratory distress syndrome, SD standard deviation

Characteristics of patients from each report NR not reported, ARDS acute respiratory distress syndrome, SD standard deviation In terms of the laboratory data at hospital admission, for the pooled data the median WBC count was 2900 (/mm3), and the median PLT count was 125 (×103/mm3); a significant difference in PLT count was observed among reports (Table 2). Based on available data on the liver function tests (three reports), the median AST and ALT levels were 280 and 52 IU/L, respectively; the levels of both liver enzymes were significantly different among reports (Table 2).
Table 2

Laboratory data at hospitalization from each report

CBC complete blood count, WBC white blood cell, PLT platelet, AST aspartate aminotransferase, ALT alanine aminotransferase

Values for WBC, PLT, AST, and ALT are given as the median value

Laboratory data at hospitalization from each report CBC complete blood count, WBC white blood cell, PLT platelet, AST aspartate aminotransferase, ALT alanine aminotransferase Values for WBC, PLT, AST, and ALT are given as the median value Differences between laboratory data at hospital admission between fatal and nonfatal cases are shown in Table 3. Leukopenia and thrombocytopenia at hospital admission were present in the fatal cases, but there were no differences in the serum levels of AST and ALT between fatal and nonfatal cases. In the linear regression analysis performed to investigate the association between blood cell counts and prognosis, WBC and PLT were dependent variables, and age, sex, and prognosis were independent variables. In the linear regression analysis performed to investigate the association between log-transformed liver function data and prognosis, log AST and log ALT levels were dependent variables, and age and prognosis were independent variables as the sample size was small enough to enable one covariate to be added. Standardized regression coefficients for the results of these linear regression analyses are shown in Table 4. Death (the value of prognosis = 1) was negatively associated with WBC and PLT counts adjusted with age and sex. In contrast, increased log AST tended to be associated with poor prognosis, but there was no significant association between survival and log ALT level. Age was negatively associated with both log AST and log ALT levels.
Table 3

Laboratory test results at hospitalization for pooled data

IQR interquartile range

Table 4

Linear regression analysis of laboratory test results at hospitalization for pooled data

WBC white blood cell, PLT platelet, AST aspartate aminotransferase, ALT alanine aminotransferase

Laboratory test results at hospitalization for pooled data IQR interquartile range Linear regression analysis of laboratory test results at hospitalization for pooled data WBC white blood cell, PLT platelet, AST aspartate aminotransferase, ALT alanine aminotransferase A comparison of the WHO-confirmed epidemiological data on human cases of H5N1 infection from December 2003 through April 2006 [1] with the results from the pooled data of our five studies reveals that the CFR for patients <19 years of age was 56.9% in the WHO report and 69.4% in our pooled data. The median time from onset of symptoms to admission was 4 days (mean 4.6 days) among all of the patients reported in our five studies and 5 days in patients reported to have died in the WHO report. The median time from onset to admission was 6 days in the pooled data. Cases were mainly identified through passive surveillance in the WHO report, whereas we also included cases collected through hospital medical records in our study. Thus, the CFR in the pooled data was higher than that of the WHO report, and the median time from onset to admission in the pooled data was longer than that in the WHO report. Our pooled data was biased to include more severe cases. Significant variations in patterns that may reflect differences in exposure related to social behavior, cultural and religious practices, access to care, and treatment or virulence of the viruses among countries have been pointed out in previous reports [4]. With respect to the virulence of viruses, viruses capable of infecting humans have been divided into groups from clades and subclades 0, 1, 2.1, 2.2, 2.3, and 7 from the phylogenetic tree for the hemagglutinin gene of highly pathogenic avian influenza A (H5N1) viruses. Clade 1 viruses were found to predominate in Vietnam, Thailand, and Cambodia in the early phase of the outbreak (2004–2005), and clade 2.1 viruses are endemic in Indonesia (2005–2006). Clade 2.2 viruses were associated with the outbreak of avian infection in Central and South Asia, the Middle East, Europe, and Africa and with human infection in western Asia, the Middle East, and Africa (including the Turkish outbreak from 2005 to 2006). The median time from onset to hospitalization were found to be unchanged among clades [11]. Differences in the proportion of fatalities were observed, but it is difficult to determine whether this difference was due to the difference in viral virulence, as other variations existed among countries. Our pooled data also included these significant variations. Although our study is characterized by a number of the limitations shown above, our results may help generate hypothetical candidates for early indicators of prognosis in patients <18 years of age with H5N1 influenza. In most of the earlier reports on H5N1 cases, the number of cases was not large enough to adjust for potential confounders. However, several published studies did investigate factors that predicted poor outcome, adjusting the confounders for the whole-age spectrum of the subjects. Kandun et al. [12] analyzed 127 confirmed infections from June 2005 through February 2008 in Indonesia and found that an individual case was significantly associated with the mortality. Liem et al. [13] reviewed medical records and analyzed 67 of 93 cases of H5N1 infection in Vietnam from January 2004 through December 2006. Applying a backward step-wise variable selection strategy for logistic regression analysis, these researchers were able to show that the presence of both neutropenia and raised ALT level predicted a poor outcome. Yu et al. [14] collected 26 H5N1 cases from hospital medical records of H5N1 cases in China from October 2005 through April 2008 and found that decreased PLT count, elevated lactic dehydrogenase level, ARDS, and cardiac failure were associated with mortality. In our study, decreased WBC and PLT counts were significantly associated with the prognosis adjusted with sex and age, but these results coincided with the results of individual previous reports. Both decreased WBC and PLT counts are considered to be common predictors of poor prognosis in H5N1 influenza patients <18 years of age. Further studies that include larger numbers of patients are needed to clarify these results.
  12 in total

1.  Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-06-30

2.  Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2008-11-14

3.  Summary of human infection with highly pathogenic avian influenza A (H5N1) virus reported to WHO, January 2003-March 2009: cluster-associated cases.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-01-15

4.  Three Indonesian clusters of H5N1 virus infection in 2005.

Authors:  I Nyoman Kandun; Hariadi Wibisono; Endang R Sedyaningsih; Widarso Hadisoedarsuno; Wilfried Purba; Hari Santoso; Chita Septiawati; Erna Tresnaningsih; Bambang Heriyanto; Djoko Yuwono; Syahrial Harun; Santoso Soeroso; Sardikin Giriputra; Patrick J Blair; Andrew Jeremijenko; Herman Kosasih; Shannon D Putnam; Gina Samaan; Marlinggom Silitonga; K H Chan; Leo L M Poon; Wilina Lim; Alexander Klimov; Stephen Lindstrom; Yi Guan; Ruben Donis; Jacqueline Katz; Nancy Cox; Malik Peiris; Timothy M Uyeki
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

5.  Avian influenza A (H5N1) infection in eastern Turkey in 2006.

Authors:  Ahmet Faik Oner; Ali Bay; Sukru Arslan; Hayrettin Akdeniz; Huseyin Avni Sahin; Yasar Cesur; Serdar Epcacan; Neziha Yilmaz; Ibrahim Deger; Baran Kizilyildiz; Hasan Karsen; Mehmet Ceyhan
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

6.  Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series.

Authors:  I Nyoman Kandun; Erna Tresnaningsih; Wilfried H Purba; Vernon Lee; Gina Samaan; Syahrial Harun; Eka Soni; Chita Septiawati; Tetty Setiawati; Elvieda Sariwati; Toni Wandra
Journal:  Lancet       Date:  2008-08-14       Impact factor: 79.321

7.  Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006.

Authors:  Nguyen Thanh Liem; Cao Viet Tung; Nguyen Duc Hien; Tran Tinh Hien; Ngo Quy Chau; Hoang Thuy Long; Nguyen Tran Hien; Le Quynh Mai; Walter R J Taylor; Heiman Wertheim; Jeremy Farrar; Dinh Duy Khang; Peter Horby
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

8.  Avian influenza A (H5N1) in 10 patients in Vietnam.

Authors:  Tinh Hien Tran; Thanh Liem Nguyen; Thi Dung Nguyen; Thi San Luong; Phuong Mai Pham; van Vinh Chau Nguyen; Thi Suu Pham; Cong Dong Vo; Thi Quynh Mai Le; Thi Thi Ngo; Bach Khoa Dao; Phuc Phat Le; Thanh Truong Nguyen; Thuy Long Hoang; Viet Tung Cao; Truong Giang Le; Dac Tho Nguyen; Hong Nga Le; Kim Tien Nguyen; Hoang San Le; Van Tuan Le; Dolecek Christiane; Tan Thanh Tran; de Jong Menno; Constance Schultsz; Peter Cheng; Wilina Lim; Peter Horby; Jeremy Farrar
Journal:  N Engl J Med       Date:  2004-02-25       Impact factor: 91.245

9.  Human disease from influenza A (H5N1), Thailand, 2004.

Authors:  Tawee Chotpitayasunondh; Kumnuan Ungchusak; Wanna Hanshaoworakul; Supamit Chunsuthiwat; Pathom Sawanpanyalert; Rungruen Kijphati; Sorasak Lochindarat; Panida Srisan; Pongsan Suwan; Yutthasak Osotthanakorn; Tanakorn Anantasetagoon; Supornchai Kanjanawasri; Sureeporn Tanupattarachai; Jiranun Weerakul; Ruangsri Chaiwirattana; Monthira Maneerattanaporn; Rapol Poolsavathitikool; Kulkunya Chokephaibulkit; Anucha Apisarnthanarak; Scott F Dowell
Journal:  Emerg Infect Dis       Date:  2005-02       Impact factor: 6.883

10.  Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China.

Authors:  Hongjie Yu; Zhancheng Gao; Zijian Feng; Yuelong Shu; Nijuan Xiang; Lei Zhou; Yang Huai; Luzhao Feng; Zhibin Peng; Zhongjie Li; Cuiling Xu; Junhua Li; Chengping Hu; Qun Li; Xiaoling Xu; Xuecheng Liu; Zigui Liu; Longshan Xu; Yusheng Chen; Huiming Luo; Liping Wei; Xianfeng Zhang; Jianbao Xin; Junqiao Guo; Qiuyue Wang; Zhengan Yuan; Longnv Zhou; Kunzhao Zhang; Wei Zhang; Jinye Yang; Xiaoning Zhong; Shichang Xia; Lanjuan Li; Jinquan Cheng; Erdang Ma; Pingping He; Shui Shan Lee; Yu Wang; Timothy M Uyeki; Weizhong Yang
Journal:  PLoS One       Date:  2008-08-21       Impact factor: 3.240

View more
  3 in total

1.  Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.

Authors:  Chen Wang; Hongjie Yu; Peter W Horby; Bin Cao; Peng Wu; Shigui Yang; Hainv Gao; Hui Li; Tim K Tsang; Qiaohong Liao; Zhancheng Gao; Dennis K M Ip; Hongyu Jia; Hui Jiang; Bo Liu; Michael Y Ni; Xiahong Dai; Fengfeng Liu; Nguyen Van Kinh; Nguyen Thanh Liem; Tran Tinh Hien; Yu Li; Juan Yang; Joseph T Wu; Yaming Zheng; Gabriel M Leung; Jeremy J Farrar; Benjamin J Cowling; Timothy M Uyeki; Lanjuan Li
Journal:  Clin Infect Dis       Date:  2014-01-31       Impact factor: 9.079

2.  First human case of avian influenza A (H5N6) in Yunnan province, China.

Authors:  Jibo He; Jing Duan
Journal:  SAGE Open Med Case Rep       Date:  2015-08-04

Review 3.  Emerging Respiratory Viruses in Children.

Authors:  Jennifer E Schuster; John V Williams
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.